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Introduction
The Coronavirus Disease 2019 (COVID-19) pandemic
has had a dramatic impact on international travel. Ac-
cording to the US Travel Association, travel expendi-
ture in 2020 declined by 42%, approximately $500 bil-
lion, when compared with 2019.[1] Dwindling inter-
national travel paralleled a concomitant decline in the
need for services provided by international travel clin-
ics. Nonetheless, relationships between travel clinics
and their clientele blossomed during this period. Hav-
ing expertise in specialized preventive care and public
health, travel clinics are equipped with the knowledge
of infectious diseases to establish new avenues for pa-
tient and community support during the pandemic and
beyond. In this perspective, approaches taken at the Di-
vision of Infectious Diseases International Travel Clinic
at the University of Louisville (UL Travel Clinic) will
be used as a model, demonstrating avenues in which
travel clinic services might pivot to meet community
needs during the ongoing COVID-19 pandemic and be-
yond.
Pre-Pandemic Travel Clinic Services
Travel clinics in the United States and worldwide have
maintained their as primary focus the provision of pre-
ventive medical care for anticipating travelers. This
preventive care utilizes a risk-based approach that ad-
dresses the epidemiology of destinations in a travel
itinerary, current health and vaccination history of the
traveler, specifics of the travel experience, and the de-
sire of the individual to minimize risks associated with
current and future travel experiences. The resultant
all-encompassing care plan includes vaccines, medica-
tions, and alternative preventive adjuncts and is influ-
enced by guidelines such as the Centers for Disease
Control and Prevention (CDC) Yellow Book and World
Health Organization (WHO) recommendations, entail-
ing risk-based guidance concerning COVID-19.[2, 3]
For more than 20 years, the UL Travel Clinic has
been operating full-service, providing care for interna-
tional travelers before, during, and after travel. Clinic
personnel—board-certified in infectious diseases, trop-
ical medicine, and infection control and International
Society of Travel Medicine–certified in travel health
(CTH®)—work closely with the Division of Infectious
Diseases’ Clinical Laboratory Improvement Amend-
ments (CLIA)–certified clinical and research laboratory
to provide their full spectrum of services. In addition
to the on-site availability of all U.S. Food & Drug Ad-
ministration (FDA)–approved vaccines, vaccine clini-
cal trials are also performed by research investigators
within the Division. The storage of these vaccines is
under meticulous management by the Travel Clinic
personnel due to fine temperature storage and docu-
mentation requirements. Physicians, advanced prac-
tice and registered nurses, public health professionals,
medical technologists, and laboratory scientists work-
ing in the UL Travel Clinic have broad competency-
based skillsets, including client care, vaccine handling
and management, vaccine administration, specimen
collection and handling, infection control, public health
surveillance and disease reporting, compliance with
Vaccine for Children (VFC) program requirements, use
of electronic medical records and state immunization
information systems, and database development. Sup-
plies maintained in the clinic include those needed for
vaccination, as well as personal protective equipment
(PPE) for specimen collection. PPE includes gowns,
gloves, masks, face shields, and N95 respirators. The
combination of an extensive resource pool and well-
designed clinic operations has enabled the provision
of concierge-level care for travelers, forming the basis
of new services provided during the COVID-19 pan-
demic.
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Travel Clinic Services During the COVID-19
Pandemic
By March 2020, international leisure travel had come to
a virtual halt. As experts well-acquainted with spec-
imen collection and PPE use and management, UL
Travel Clinic personnel switched gears to provide as-
sistance to the local health care scene. They began
working with local hospitals and health care facilities to
expand testing capacity for in-patients and long-term
care residents during the initial wave of the pandemic.
In addition, the laboratory personnel began working
with Luminex to validate a laboratory-developed poly-
merase chain reaction (PCR) test for the SARS-CoV-2
virus. This test was validated by FDA emergency use
authorization (EUA) in April 2020 [4-6], subsequently
enabling Travel Clinic personnel to begin providing
COVID-19 PCR tests for the community, as well as busi-
nesses engaged in international travel. Bioinformati-
cians and database managers in the Division of Infec-
tious Diseases were consulted to assist in development
of a REDCap® database to facilitate electronic registra-
tion for COVID-19 testing and support public health
surveillance and report.[7]
Testing is performed via a curbside service (Figure 1).
Individuals seeking COVID-19 testing are emailed a
link to the online registration database. Upon arrival
to the clinic parking lot, individuals remain in their
cars while clinic personnel perform the nasopharyn-
geal specimen collection. Thereafter, the PCR labora-
tory tests are conducted by laboratory personnel, with
results made available within 24 hours’ turnaround
time. With the recommencement of international travel
in the Fall of 2020, the database was used to provide
documentation of test results required by airlines and
various international immigration regulations. Face-to-
face engagement for travel-related counseling occurred
virtually via a HIPAA-compliant Zoom platform, while
post-consult vaccinations would be carried out curb-
side in the parking lot.
In December 2020, when the COVID-19 vaccines were
released under EUA, the Travel Clinic was able to in-
crease the capacity of local vaccination efforts. Mass
vaccination training was provided as part of the
Louisville Vaccination efforts (LouVax), and Travel
Clinic personnel assisted with the 17-week operation of
LouVax Broadbent, the drive-through community vac-
cination site (Figure 2). At that site, over 105,000 doses
of vaccine were administered by a workforce of more
than 2,000 health care workers; Travel Clinic personnel
developed and coordinated the vaccine handling and
vaccine administration training program for that work-
force.[8] Due to clinic experience and demonstration of
vaccine handling competence evidenced by participa-
tion in the state’s Vaccines for Children (VFC) program,
the Travel Clinic was able to obtain COVID-19 vaccines
on site and provide them to members of the community
on a walk-in/drive-up basis.
Community engagement throughout the first year of
the COVID-19 pandemic also provided opportunities
for research within the Division of Infectious Diseases.
With the involvement of researchers, protocols were
developed to engage patients seeking COVID-19 test-
ing and/or vaccination at the Travel Clinic in research
participation. Personnel of the Travel Clinic assisted
with the exchange of information regarding Division
research activities and the enrollment of research par-
ticipants. The drive-up mode of research testing was
conducted by the Travel Clinic when in-facility test-
ing was not required by the research protocol. Envi-
ronmental infection control practices were in place to
safely facilitate interactions that required in-facility re-
search testing.
Re-imagining Travel Clinic Services Be-
yond the COVID-19 Pandemic
The COVID-19 pandemic has both required and en-
abled a transformation of services provided by inter-
national travel clinics. The use of technologies such as
those enabling virtual connections for pre-travel coun-
seling (e.g., Zoom), increasing use of laboratory test-
ing (e.g., PCR for COVID-19) as part of travel services,
and integration of drive-through or curbside vaccina-
tion are just a few examples of services that interna-
tional travel clinics may encompass in 2022 and be-
yond.
Based on the experiences gleaned from the 2020–2021
phase of the COVID-19 pandemic and its impact on the
UL Travel Clinic, approaches to reimagine the services
of international travel clinics are outlined below:
• Develop processes to engage with international
travelers using a virtual component (e.g., Zoom).
• Ensure that the virtual engagement process pro-
tects the privacy and health information of the
client.
• Train clinic personnel in modes of disease trans-
mission and provide them with appropriate PPE,
including fit-tested respirators.
• Maintain stock of PPEs, injection supplies, and
specimen collection equipment, recognizing the
typical long shelf life of many of the aforemen-
tioned items upon storage under proper environ-
mental conditions.
• Train clinic personnel to engage with clients, ad-
minister vaccines, and perform specimen collec-
tion via drive-through or curbside approaches.
• Establish and maintain a working relationship
with a CLIA-certified laboratory.
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Figure 1. Curbside testing service process for SARS-CoV-2 infection.
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Figure 2. LouVax drive-through vaccination for SARS-CoV-2 at Broadbent Arena, Louisville, KY.
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• Evaluate current clinic location, space, and capa-
bilities to enable expansion or changes in client
engagement.
• Establish and maintain working relationships
with local public health departments or districts.
• Train clinic personnel regarding local reportable
disease and surveillance regulations, including
clinic responsibilities for reporting of results.
• Engage clients, possibly through an informal ad-
visory board process, to better understand needs
and expectations.
• Develop and implement competency-based train-
ing to ensure clinic personnel are competent to
perform every aspect of their work.
• Engage with local university/universities and es-
tablish dialogue regarding travel clinic capabili-
ties as a means of furthering local research capa-
bilities and capacities.
These points are by no means all-inclusive but are
meant to be a starting point to facilitate discussions
across the public health and travel clinic industries.
Services provided by international travel clinics are vi-
tal for the health and safety of the population. Enabling
continuation and expansion of those services to address
the current pandemic, as well as emerging pathogens
or new pathogens, is crucial for the health and welfare
of populations worldwide.
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